IGMS

IGM Biosciences (IGMS)

IGM Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IGMS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/09	05:10	GlobeNewswire Inc.	IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/07	20:00	GlobeNewswire Inc.	IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference	NASDAQ:IGMS	IGM Biosciences Inc
2024/04/17	21:30	GlobeNewswire Inc.	IGM Biosciences Announces Refocusing of Sanofi Collaboration	NASDAQ:IGMS	IGM Biosciences Inc
2024/04/10	20:00	GlobeNewswire Inc.	IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06:27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06:10	GlobeNewswire Inc.	IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/06	09:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/02/01	21:00	GlobeNewswire Inc.	IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/08	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	10:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	08:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	08:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/03	21:00	GlobeNewswire Inc.	IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07:36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/06	06:01	GlobeNewswire Inc.	IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/01	19:32	PR Newswire (US)	Bulletin from Extraordinary General Meeting in Medivir AB (publ)	NASDAQ:IGMS	IGM Biosciences Inc
2023/11/30	10:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc